UnknownNCT06636812
Losartan and Emotional Processing in Young People
Medication studyAges 16–20United KingdomAnxiety
Understand this study
Who could participate?
Listed age limits: 16 years to 20 years.
- Listed locations
- OxfordSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 7, 2024
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 60
- Sponsor
- University of Oxford
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United Kingdom
- Age range
- From 16 Years to 20 Years
- Official registry ID
- NCT06636812
- Official title
Show the full official title
The Effects of Single-dose Losartan on the Processing of Emotional Information in Healthy Adolescents: a Randomised Controlled Study
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Oxford
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Oxford, a university.
Does this study involve medication?
Yes. The study involves medication, including Losartan potassium.
Who can participate?
Listed age limits: 16 years to 20 years.
Want to explore more studies?
Explore studiesRelated studies
Eye Movement Desensitisation and Reprocessing (EMDR) to Improve Mental Health Following Intensive Care Admission
Metacognitive Therapy for Common Mental Health Problems in Autistic CYP: A Case Series